US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...
CVS Health (NYSE:CVS) subsidiary Oak Street Health has reached a $60M settlement with the Department of Justice to resolve ...
The Anti-Kickback Statute prohibits anyone from offering or paying, directly or indirectly, money or anything else of value ...
The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially ...
This week's dividend activity included increased payouts from Microsoft (NASDAQ:MSFT) and JPMorgan (NYSE:JPM) as well as ...
Before the primary care chain was purchased by CVS Health, Oak Street illegally paid marketing agents for referring Medicare-eligible seniors to its clinics, according to the Department of Justice.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback